Article
[Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Rinsho byori. The Japanese journal of clinical pathology - 1 Jul 2005
Yagi Hideo
Abstract excerpt
Ticlopidine is an antiplatelet agent that interferes with platelet membrane function by inhibiting adenosine diphosphate-induced platelet activation. It is used in an increasing number of cases of cerebrovascular disease, unstable angina, coronary artery stenting, and peripheral vascular diseases. It has rare but serious adverse reactions, including thrombotic thrombocytopenic purpura (TTP). TTP is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
